Skip to main content

Table 5 Patient characteristics at baseline: left MTA score of 0 or 1 versus 2, 3 or 4

From: The relationship of weight change trajectory with medial temporal lobe atrophy in patients with mild Alzheimer’s disease: results from a cohort study

 

MTA score 0 or 1

MTA score 2, 3, 4

P

Age (year): n, median [25th -75th percentile]

16, 75.0 [72.0 - 78.8]

198, 79.0 [75.8 - 82.0]

0.003b**

Women, n (%)

11 (68.8)

121 (61.1)

nsc

Social status

   

 alone, n (%)

10 (62.5)

83 (43.5)

nsc

 with partner, n (%)

5 (31.3)

103 (53.9)

 other*, n (%)

1 (6.3)

5 (2.6)

CIRS (score): n, median [25th -75th percentile]

16, 5.0 [4.0 - 6.0]

198, 6.0 [4.0 - 8.0]

nsb

Polypharmacy, n (%)

8 (50.0)

105 (53.3)

nsc

Use of informal care, n (%)

13 (81.3)

169 (85.8)

nsd

Use of professional care, n (%)

6 (37.5)

93 (47.7)

nsc

MMSE (score): n, median [25th -75th percentile]

16, 25.0 [23.0 - 26.8]

196, 23.0 [20.0 - 15.0]

0.017b**

Clock-drawing test (score): n, median [25th -75th percentile]

15, 3.0 [1.0 - 4.0]

178, 3.0 [2.0 -5.0]

nsb

Presence of BPS, n (%)

5 (31.3)

46 (23.8)

nsd

Weight (kg): n, mean ± SD

16, 68 ± 12

198, 74 ± 12

nsa

BMI (weight/(height)2): n, median [25th -75th percentile]

16, 25.7 [21.1 - 27.0]

187, 25.9 [23.5 - 29.1]

nsb

Use of ONS, n (%)

0 (0.0)

1 (0.8)

nsd

Appetite

   

 good, n (%)

14 (87.5)

156 (93.4)

nsd

 poor, n (%)

2 (12.5)

11 (6.6)

Self-reported weight loss, n (%)

2 (12.5)

26 (14.6)

nsd

  1. *Other, that is: with son or daughter, brother or sister; **significant, that is P <0.05. aIndependent sample t test; bMann-Whitney U test; cPearson chi-square test; dFisher’s exact.
  2. MTA, medial temporal lobe atrophy; P, probability; n, number of patients; ns, not significant; CIRS, cumulative illness rating scale; MMSE, mini mental state examination; BPS, behavioral and psychological symptoms; SD, standard deviation; BMI, body mass index; ONS, oral nutritional supplement.